TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

DESONIDE

DESONIDE
Approved 1972-01-04
Jump to: Indications Approvals Trials Competitors Safety Patents
20
Indications
--
Phase 3 Trials
54
Years on Market

Details

Status
Discontinued
First Approved
1972-01-04
Routes
TOPICAL
Dosage Forms
OINTMENT, CREAM, GEL, LOTION

Companies

GLENMARK PHARMS LTD CADILA ALEMBIC SUN PHARMA CANADA PAI HOLDINGS PHARM SENORES PHARMS GLENMARK SPECLT ENCUBE ETHICALS TARO COSETTE FOUGERA PHARMS PADAGIS US Hikma
Active Ingredient: DESONIDE

DESONIDE Approval History

Loading approval history...

What DESONIDE Treats

20 FDA approvals

Originally approved for its first indication in 1972 . Covers 20 distinct patient populations.

  • Other (20)
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

ClinicalTrials.gov ↗ Pro

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

DESONIDE FDA Label Details

Pro

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

FDA Approval: ANDA209996 → Patents: FDA Orange Book → Trials: ClinicalTrials.gov →

Data sourced from official FDA and NIH databases. Click links to verify on original sources.